date,title,source
Oct-26-18,Ardelyx Presents New Preclinical Data Demonstrating Synergy between Tenapanor and Sevelamer When Dosed in Combination for Elevated Serum Phosphorus,PR Newswire
Nov-07-18,Ardelyx: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Ardelyx Reports Third Quarter 2018 Financial Results and Recent Highlights,PR Newswire
Nov-13-18,Ardelyx Announces FDA Acceptance of the Filing of its New Drug Application for Tenapanor for the Treatment of Patients with IBS-C,PR Newswire
Nov-26-18,What Type Of Shareholder Owns Ardelyx Incs (NASDAQ:ARDX)?,Simply Wall St.
